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Abstract
Background: Mouse models offer an essential tool to unravel the impact of genetic mutations on autism-related
phenotypes. The behavioral impact of some important candidate gene models for autism spectrum disorder
(ASD) has not yet been studied, and existing characterizations mostly describe behavioral phenotypes at adult
ages, disregarding the developmental nature of the disorder. In this context, the behavioral influence of
CNTN4, one of the strongest suggested ASD candidate genes, is unknown. Here, we used our recently
established developmental test battery to characterize the consequences of disruption of contactin 4 (Cntn4) on
neurological, sensory, cognitive, and behavioral phenotypes across different developmental stages.
Methods: C57BL/6J mice with heterozygous and homozygous disruption of Cntn4 were studied through an extensive,
partially longitudinal, test battery at various developmental stages, including various paradigms testing social and
restricted repetitive behaviors.
Results: Developmental neurological and cognitive screenings revealed no significant differences between genotypes,
and ASD-related behavioral domains were also unchanged in Cntn4-deficient versus wild-type mice. The impact of
Cntn4-deficiency was found to be limited to increased startle responsiveness following auditory stimuli of different high
amplitudes in heterozygous and homozygous Cntn4-deficient mice and enhanced acquisition in a spatial learning task
in homozygous mice.
Conclusions: Disruption of Cntn4 in the C57BL/6J background does not affect specific autism-related phenotypes
in developing or adult mice but causes subtle non-disorder specific changes in sensory behavioral responses and
cognitive performance.
Keywords: CNTN4, Autism spectrum disorder, 3p deletion syndrome, Developmental trajectories, Mouse model,
Behavior, Reversal learning, Negative findings, Hyperreactivity, Schizophrenia
Background
Autism spectrum disorder (ASD) is a behaviorally de-
fined developmental disorder with a strong genetic com-
ponent [1, 2]. The identification of genetic risk factors
such as common genetic variants, rare inherited and de
novo mutations have lead to the implication of hundreds
of different genes [3, 4]. These findings illustrate the
complexity and heterogeneity of the genetic architecture
of ASD.
Subsequently, mouse models are being used to un-
ravel the functional impact of implicated genes on ASD
phenotypes in a controlled genetic and environmental
background. However, knowledge of the impact on
cognitive and behavioral development of the majority
of these genes is missing or incomplete [5], and most
behavioral characterizations of animal models are limited
to adult phenotypes disregarding the developmental
nature of ASD [6].
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Here, we characterize the impact of contactin 4 (Cntn4)
null mutation on behavioral development, using our re-
cently developed longitudinal test battery for mice that
tests a wide array of neurological, cognitive, and behav-
ioral parameters across development starting from 3 weeks
of age [6].
CNTN4 is an axonal glycoprotein belonging to the
contactin family, a six-member subgroup of the im-
munoglobulin superfamily of cell adhesion molecules
[7]. CNTN4 is known to act as an axon guidance mol-
ecule in the establishment of olfactory neural circuitry
during neural development [8] and promotes target-
specific axon arborization of a subset of retinal ganglion
cells onto the nucleus of the optic tract [9]. Knowledge of
the neurobiological functions of CNTN4 in normal and
abnormal development of brain systems are far from
complete.
The CNTN4 gene has been implicated in ASD due to
its presence in the genetic locus of the 3p-deletion
syndrome, a mental retardation syndrome [10]. Subse-
quently, evidence for a role of CNTN4 has been ac-
cumulated [11–14] but has also been questioned [15, 16].
Three cases carrying a copy number variant (CNV) in the
CNTN4 gene were reported by the Autism Genome Pro-
ject Consortium (AGP) [12]. Deletions and duplications in
the CNTN4 gene or its promoter region were found in
10 families of the Autism Genetic Resource Exchange
(AGRE) collection [13]. In the Autism Case-Control
cohort (ACC), deletion in the promoter region of
CNTN4 was found in three cases but not in controls
[13]. Association of CNTN4 with developmental disor-
ders such as ASD further seems supported by the pro-
tein’s neurobiological functions [2, 7].
Follwoing these observations, we performed a careful
longitudinal functional characterization of homozygous
and heterozygous disruptions of Cntn4 to resolve the im-
pact of this gene on behavioral and cognitive development.
Methods
Generation and breeding of Cntn4 mice
Cntn4-deficient mice were kindly provided by Dr. Yoshihiro
Yoshihara (RIKEN, Japan) [8]. These mice were generated
using a standard gene-targeting method as previously de-
scribed. A targeting vector was designated to mutate the
translation start codon (ATG) in the exon 2 of the Cntn4
gene into a stop codon (TAG) and introduce a pgk-neo
selection marker. Consequently, these mice were back-
crossed with C57BL/6 mice more than nine times. Upon
arrival in the University Medical Center Utrecht, the mice
were re-derived, followed by heterozygous breeding for the
use in our experiments.
All animals were born and weaned at the University
Medical Center Utrecht. Average nest size of Cntn4
litters was 7.2, and the litters larger than 10 animals per
litter were culled back to average 7. The minimum litter
size used for behavioral experiments was four animals
per litter. Detailed information on the genotyping of
Cntn4 mice is provided in Additional file 1.
Given the extensive number of tests, the mice were
spread over four different batches. Table 1 provides the
order of behavioral testing and the number of animals
per genotype per batch. Phenotypic assessments in
batches 1, 2, and 3 were performed at the University
Medical Center Utrecht. Batch 4 was transported and
tested at Sylics (Synaptologics BV, Amsterdam, The
Netherlands).
Table 1 Overview of the behavioral tests per batch
Age Task Batch Subjects (n)
3 weeks Juvenile social interaction Batch 1 + 2 6–7 genotype-matched pairs per genotype
4 weeks Extended SHIRPA screen Batch 1 + 2 19–26 per genotype
6 weeks Extended SHIRPA screen Batch 1 + 2 19–26 per genotype
8 weeks Extended SHIRPA screen Batch 1 + 2 19–26 per genotype
Adult Extended SHIRPA screen Batch 1 10–15 per genotype
Open field Batch 1 10–15 per genotype
Elevated plus maze Batch 1 10–15 per genotype
Social discrimination Batch 1 10–15 per genotype
Buried food test Batch 2 9–11 per genotype
Set shifting-reversal task Batch 2 9–11 per genotype
Social approach in 3-chamber Batch 3 12 per genotype
Novel object exploration task Batch 3 12 per genotype
Barnes maze-reversal task Batch 4 16 per genotype
Pre-pulse inhibition Batch 4 16 per genotype
Animals in batch 1 + 2 were weaned at post-natal day 21. Batch 3 + 4 animals were weaned at post-natal day 28
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All experiments were approved by the ethical commit-
tee for animal experimentation of the University Medical
Center Utrecht and Free University Amsterdam and per-
formed according to the institutional guidelines that are
in full compliance with the European Council Directive
(86/609/EEC).
Developmental neurological and behavioral screening
Cntn4−/−, Cntn4+/−, and wild-type male littermates were
subjected to our previously described longitudinal screen-
ing strategy (extended SHIRPA battery) testing an array of
neurological, behavioral, and cognitive parameters at 4, 6,
8, and 11 weeks of age [6, 17]. The longitudinal test bat-
tery includes the assessment of autism-related traits such
as motor stereotypies (e.g., self-grooming) and sensori-
motor coordination (e.g., latency to fall from the rotarod).
Detailed information on behavioral testing is provided in
Additional file 1.
Screening of social behaviors and restricted repetitive
behaviors
Abnormalities in social interaction behaviors were assessed
in the juvenile social interaction test (3 weeks of age) [18],
followed by a three-chamber social approach [18], and a
2-day social discrimination paradigm in adult age animals
[19]. Stereotypic movements, restricted interests, and re-
petitive patterns of behavior were analyzed in the novel
object investigation task during exposure to four novel
toys [20]. Cognitive flexibility was assessed by multi-trial
associative learning in an extensive set-shifting paradigm
[6], as well as a Barnes maze spatial learning task includ-
ing reversal [21]. Acoustic startle response and sensori-
motor gating were assessed in the pre-pulse inhibition
(PPI) test [19]. Anxiety-related behaviors were tested in
the elevated plus maze and open field [6]. Statistical
analyses are described in the Additional file 1.
Results
eSHIRPA assays
The eSHIRPA (extended SmithKline Beecham, Harwell,
Imperial College and Royal London Hospital phenotype
assessment) screen did not show differences between the
Cntn4+/− mice, Cntn4−/− mice, and wild-type controls at
4, 6, 8, or 10 weeks of age in general health, body weight,
and neurological reflexes nor in the development of
various locomotor parameters including total distance
moved, movement velocity, and movement duration
(Figs. 1a–d, Table 2). Moreover, we found no develop-
mental differences in the amount of self-grooming or
sensorimotor coordination on the rotarod (Figs. 1e–f ).
Social interaction behavior
The juvenile social interaction test revealed no differences
in the amount of social sniffing, anogenital sniffing, or
social grooming (Fig. 1g) between the Cntn4+/−, Cntn4−/−,
and wild-type control mice. In the adult three-chamber
test, all genotypes showed a clear preference for explor-
ation of a mouse over an object, and no genotype differ-
ences in the amount of social exploration were observed
(Fig. 1h). Furthermore, genotypes were equally capable to
distinguish between a familiar mouse and a novel mouse
in a social recognition paradigm, both at 5 min and 24 h
after initial exposure (Fig. 1i).
Restricted and repetitive behaviors
There were no differences in the grooming behavior
between the Cntn4+/−, Cntn4−/−, and wild-type control
mice at adult age, in line with the amount of grooming
observed in the longitudinal eSHIRPA screening (Fig. 2a).
We also found no genotype differences in restricted
interest or in repetitive patterns of behavior in the novel
object investigation task during the exploration of the
four novel toys (Fig. 2b, c).
We additionally analyzed cognitive flexibility through
the assessment of reversal learning in a set-shifting
task. Prior to this task, we ascertained intact olfactory
capacities, as we found no genotype differences in the
latency to find a buried piece of food. In the set-shifting
task, all genotypes were equally able to associate a food
reward with a specific digging material or odor, as was
evident through the performance of simple, compound
discrimination and intra- and extra-dimensional shifts
(Fig. 2d).
The reversal-learning phase of this test yielded an
inconclusive result, as the genotype effect that we
observed on reversal learning was only significant
(ANOVA p = 0.04) in one of the two outcome measures
(i.e., the number of trials to reach the criterion but not in
errors to reach criterion). Moreover, a shift cost in wild-
type mice was observed in errors to reach criterion,
although not in the number of trials to reach criterion.
Given this inconclusive result, we tested reversal-
learning performance in a different paradigm. In this
Barnes maze reversal-learning paradigm, we confirmed
that Cntn4 does not affect reversal learning, as all
genotypes needed equal amount of time as well as dis-
tance before reaching the re-located escape hole (Fig. 2f).
In contrast to the set-shifting test, we observed a shift cost
that was observed in all genotypes in the reversal phase of
the Barnes maze test (Fig. 2e, f ).
Responses to sensory stimuli and anxiety-related
behaviors
The startle response was consistently increased in the
Cntn4+/− and Cntn4−/− mice at different high amplitudes,
although the startle threshold was not significantly differ-
ent between genotypes (Figs. 2g, h). No significant effects
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were found on pre-pulse inhibition at both inter-stimulus
intervals of 30 and 100 ms (Figs. 2i, j).
The increased startle response to auditory stimuli of
the different high amplitudes seemed not to result
from increased anxiety levels, as Cntn4+/−, Cntn4−/−
mice and wild-type controls did not differ in their el-
evated plus maze (Fig. 2k) and open-field exploratory
behaviors (Figs. 2l).
Discussion
We present a comprehensive assessment of the impact
of the ASD candidate gene CNTN4 on a variety of
neurological, behavioral, and cognitive aspects of devel-
opment. We found no effect of Cntn4 deficiency on
ASD-related behavioral mouse paradigms such as the ju-
venile social interaction test, the three-chamber test,
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Fig. 1 Developmental neurological and behavioral screen and analysis of social behaviors in Cntn4-deficient mice. a Distance moved
(rmANOVA genotype, F(2,63) = 0.760, p= .472), b movement velocity (rmANOVA genotype, F(2,63) = 1.256, p= .292), c movement duration (rmANOVA
genotype, F(2,63) = 0.342, p= .479), d body weight (rmANOVA genotype, F(2,63) = 0.588, p= .558), e latency to fall of the accelerating rotarod (rmANOVA
genotype, F(2,64) = 0.110, p = .896), and f time spent self-grooming (rmANOVA genotype, F(2,64) = 1.038, p = .360) at pre-adolescence (4 weeks),
adolescence (6 weeks), early adulthood (8 weeks), and adulthood (10 weeks) (n = 19–26 per genotype) during the eSHIRPA test. g Social sniffing
(owANOVA, F(2,16) = 2.926, p = .083), anogenital sniffing (owANOVA, F(2,16) = 0.055, p = .946), and social grooming (owANOVA, F(2,16) = 0.334, p = .721)
during the juvenile social interaction test in genotype-matched mice at post-natal day 21 (n = 6–7 pairs of genotype-matched interacting animals per
genotype). h Social exploration (owANOVA between genotypes, F(2,32) = 0.599, p = .556) as a function of exploration of the cage with the novel mouse
versus the empty cage during the three-chamber task (n = 12 per genotype). i Social exploration during the social discrimination test following a 5-min
inter-trial interval (owANOVA between genotypes F(2,36) = 0.138, p = .872) and a 24-h inter-trial interval (owANOVA between genotypes F(2,36) = 0.096,
p = .909), with exploration of the novel mouse as fraction of the total duration of social exploration (n = 10–15 per genotype). Data are presented as
means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.05
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also did not observe developmental neurological, behav-
ioral, or cognitive abnormalities in the extended SHIRPA
screen.
The reversal-learning phase of the set-shifting task yielded
an inconclusive result, as no shift cost was observed in wild-
type animals for the number of trials to reach criterion. In-
deed, the genotype difference that was observed in the num-
ber of trials to reach the criterion in the reversal-learning
phase was rather caused by lack of shift cost in wild-type
animals than a reversal-learning deficit in the Cntn4−/− mice.
In line with this reasoning, when we compared the outcome
of Cntn4−/− mice in the reversal-learning phase with the re-
sults obtained for C57BL/6J mice obtained in a previous
study, we find no genotype difference in this phase of the
set-shifting task [6]. In the Barnes maze reversal-learning
paradigm, we also did not find a reversal-learning deficit.
Based on the summary of these data, we conclude that
Cntn4 disruption has no effect on cognitive flexibility.
Table 2 Physical and neurological features during the different phases of the extended SHIRPA primary screen.
Age (weeks) 4 6 8 Adult
Test WT +/− −/− Sig. WT +/− −/− Sig. WT +/− −/− Sig. WT +/− −/− Sig.
Subjects (n) 19 26 22 19 26 22 19 26 22 13 15 10
Body position (active) 95 96 100 0.22 100 100 100 1.00 100 96 100 0.46 100 100 100 1.00
Body position (inactive) 0 4 0 0 0 0 0 4 0 0 0 0
Body position (excessive activity) 5 0 0 0 0 0 0 0 0 0 0 0
Tremor (absent) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Palpebral closure (eyes open) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Coat appearance tidy and groomed 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Whiskers (present) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Lacrimation (absent) 100 96 100 0.45 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Defecation (quantity) 1.9 1.6 2.0 0.47 3.1 2.5 1.9 0.06 2.8 2.3 2.4 0.61 3.8 3.7 3.2 0.70
± SEM 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.4 0.7 0.7 0.9
Transfer arousal (brief freeze) 11 15 14 0.70 11 19 9 0.71 11 8 0 0.16 8 0 10 0.50
Transfer arousal (immediate movement) 89 85 86 89 81 91 89 92 100 92 100 90
Gait (fluid) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Tail elevation (horizontal extension) 100 100 100 1.00 95 100 100 0.28 100 100 100 1.00 100 100 100 1.00
Tail elevation (straub tail) 0 0 0 5 0 0 0 0 0 0 0 0
Startle response (preyer reflex) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Touch escape (flight prior to touch) 79 73 77 0.88 89 85 73 0.35 63 88 68 0.05 85 87 100 0.45
Touch escape (response to touch) 21 27 23 11 15 27 37 12 32 15 13 0
Positional passivity (struggles) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Skin color (pink) 95 100 100 0.28 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Skin color (blanched) 5 0 0 0 0 0 0 0 0 0 0 0
Trunk curl (absent) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Limb grasping (absent) 100 92 100 0.20 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Pinna reflex (present) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Corneal reflex (present) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Contact righting reflex (present) 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Evidence of biting (none) 79 77 77 0.99 84 88 100 0.18 100 100 100 1.00 100 100 100 1.00
Grip (OK) 100 96 100 0.36 95 96 100 0.59 100 100 100 1.00 100 100 90 0.24
Full puberty 89 81 100 0.30 100 100 100 1.00 100 100 100 1.00 100 100 100 1.00
Cntn4+/−, Cntn4−/−, and wild-type (WT) control mice were screened in the Perspex jar for body position (active, inactive, or excessively active), tremor (present or
not), palpebral closure (eyes open or not), coat appearance (well groomed or irregularities like piloerection), whiskers (intact or trimmed), and lacrimation (present
or not). In the arena, the mice were screened for transfer arousal (freezing or immediate movement), gait (fluid or not), tail elevation (dragging, horizontal, or
straub tail), startle response (preyer reflex, no response, or additional response), and touch escape (response to touch or flight prior to touch while finger
approaches). Mice were transferred out of the arena to observe positional passivity (struggling by different types of handling), skin color (color of plantar surface of
forelimbs), trunk curl (forward curling with head to abdomen), limb grasping (clasping of rear limbs), pinna reflex (presence of ear retraction), corneal reflex (presence
of eyeblink), contact righting reflex, evidence of biting, grip (grasping of grid), vocalization, and puberty (presence of sex organs). Sig. represents statistical significance
of between-genotype differences. Data are presented as a percentage of the total number of animals per genotypes, except for defecation (count of the fecal boli)
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Fig. 2 (See legend on next page.)
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Non-ASD-specific effects at adult ages were indicated
by increased startle response to auditory stimuli of dif-
ferent high amplitudes and by faster escape hole finding
during subsequent days of acquisition in the Barnes
maze.
Hyperresponsivity to acoustic stimuli is related to
many neurodevelopmental disorders and has also been
reported in ASD [22]. In addition, acoustic hyperrespon-
sivity in patients with fragile X syndrome is known to be
consistent with animal model data [23]. Similar to our
findings, an increased startle response to acoustic stimuli
was recently described in children with ASD [24], al-
though these were in response to weak stimuli in con-
trast to the high amplitudes we found. The observed
hyperresponsivity in Cntn4-deficient mice was unrelated
to anxiety levels, as mice showed similar exploratory be-
haviors in classical anxiety behavioral tests, such as the
elevated plus maze and open field. Although speculative,
the increased startle response together with the en-
hanced acquisition in the Barnes maze could indicate
that Cntn4 deficiency in the C57BL/6J background leads
to a state of increased behavioral responsiveness without
overt anxiety or avoidance behavior in mice [25].
Together, the findings show that in the C57BL/6J back-
ground, disruption of Cntn4 does not lead to substantial
behavioral defects related to autistic development. A lim-
ited behavioral penetrance of CNTN4mutations on autistic
development may be consistent with a recent study that
revisited the association of contactins, including CNTN4,
with ASD [16]. The behavioral phenotype of Cntn4 mice
contrasts other previously studied genetic ASD models
[18]. For instance, Shank3 or Pten mice show extensive im-
pairments in social interaction and sensorimotor pheno-
types and are therefore regarded as translational models
for ASD [26–28].
Although ASD-related phenotypes in Cntn4-deficient
mice were observed, our findings do have relevance for
neurodevelopmental disorder research. The specific pheno-
types observed in Cntn4-deficient mice may be used to
study the mechanisms underlying increased responsiveness
or vigilance, a trait observed across many different human
disorders such as attention-deficit hyperactivity disorder,
post-traumatic stress disorder, and schizophrenia [29–31].
Cntn4-deficient mice may serve as a model to study the
mechanistic underpinnings of behavioral states in which
vigilance is altered. Indeed, common single-nucleotide var-
iants in the CNTN4 locus have recently been associated
with other neuropsychiatric disorders, such as schizophre-
nia [32], perhaps pointing to a non-disorder specific con-
tribution of this cell adhesion gene in neuropsychiatric
pathogenesis. In addition, a role for Cntn4, was recently
shown in target-specific arborization during development
of the accessory optic system [9]. Our study shows the
importance of detailed developmental neurological, behav-
ioral, and cognitive characterization of genetic animal
models to complement human genetic studies in ASD and
related disorders.
Conclusions
In our test battery, disruption of Cntn4, a prominent ASD
candidate gene, had no effect on cognitive and behavioral
development or ASD-specific phenotypes. At adult age,
we could detect an effect of Cntn4 disruption on an adult
sensory behavioral and a spatial cognitive feature.
Additional file
Additional file 1: Detailed information on genotyping, behavioral
testing and statistical analyses.
(See figure on previous page.)
Fig. 2 Restricted repetitive behaviors and sensory-sensitivity screening of adult Cntn4 mice. Restricted and repetitive behavior in the novel
object investigation task. a Stereotypic movements as total time spent grooming (owANOVA, F(2,33) = 0.431, p = .653). b Restricted interest as
frequency-based percentage preference of exploration of each of the four novel toys (1st preference owANOVA, F(2,33) = 0.446, p = .644; 2nd preference
owANOVA, F(2,33) = 1.569, p = .223; 3rd preference owANOVA, F(2,33) = 1.208, p = .312; 4th preference owANOVA, F(2,33) = 0.236, p = .791). c Repetitive toy
exploration patterns based on repetitive sequences of three elements (owANOVA, F(2,33) = 0.760, p = .476) and four elements (owANOVA,
F(2,33) = 0.227, p = .798) (n = 12 per genotype). d Reversal learning during the set-shifting reversal-learning task. X-axis represents the different sub-tasks.
Y-axis represents the total number of trials that were needed to reach the criterion of 8 correct digs in 10 consecutive trials (n= 9–11 per genotype).
e–f Spatial learning and reversal learning during the Barnes maze paradigm. Y-axis represents the daily mean of latency to find the escape hole during
e the acquisition phase (rmANOVA genotype, F(2,44) = 4.151, p= .022) and f the reversal-learning phase (rmANOVA genotype, F(2,43) = 0.830, p= .830) after
replacing the escape to the other side of the maze (n= 16 per genotype). Startle and PPI results in Cntn4 mice, with g startle magnitude as function of
startle stimulus in all genotypes (MANOVA, F(24,70) = 1.984, p= 0.014), h startle threshold (owANOVA, F(2,45) = 1.542, p= 0.225), i–j pre-pulse inhibition tested
with different pre-pulse intensities with inter-stimulus interval (ISI) at 30 ms (two-way ANOVA, F(2,135) = 2.376, p = 0.096) and at 100 ms (two-
way ANOVA, F(2,135) = 1.1927, p = 0.306; n = 16 per genotype). Anxiety behavior during the elevated plus maze test and open-field test mea-
sured as k elevated plus maze anxiety and as total time spent on the open arms (owANOVA, F(2,36) = 1.450, p = 0.248), l total time spent in
the center (owANOVA, F(2,36) = 0.165, p = 0.848), middle (owANOVA, F(2,36) = 0.413, p = 0.665), and outer zones (owANOVA, F(2,36) = 0.125,
p = 0.883) of the open field (n = 10–15 per genotype). Data are presented as means ± SEM; *p < 0.05. SD simple discrimination, CD compound
discrimination, IDS I–IV intra-dimensional shift I–IV, IDS-reversal reversal of intra-dimensional shift IV (owANOVA, F(2,27) = 3.487, p = .045;
Dunnett’s t, WT vs HET p = 0.037, WT vs KO p = 0.092), EDS extra-dimensional shift (owANOVA, F(2,27) = 1.416, p = .260)
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